Fidelity® Select Biotechnology Portfolio

Class No Load (FBIOX)
Scorecard
4 / 5 Stars
Lipper
5 5 4 5 4
Zacks Investment Research
3 (Hold)
Standard & Poor's
5 / 5 Stars
TheStreet.com
A- (Buy)

Fund Performance

The fund's Value Line Growth Persistence rank, which awards funds that consistently outperform their broad universes, is 2 for one year, 2 for five years, and 2 for 10 years. Scores are on a 1 to 5 scale, with 1 being the best and 5 the worst.

Value Line 2014-03-12

Hypothetical Growth of $10,000

Updated 02.28.2014

Trailing Total Returns

Updated 02.28.2014

Total Return % + / - MSCI ACWI NR USD + / - S&P 1500 Health Care TR % Rank
Year-to-date 21.87 21.24 15.10 1
1-Month 7.75 2.92 1.90 15
3-Month 23.56 21.19 15.96 1
6-Month 37.74 24.17 16.30 1
1-Year 84.28 66.12 44.86 1
3-Year (Annualized) 47.56 39.21 23.07 1
5-Year (Annualized) 34.20 14.63 10.02 1
10-Year (Annualized) 15.68 8.82 6.51 7